As screening guidelines evolve and GI care increasingly shifts to outpatient settings, ASCs are seeing significant growth in colonoscopy volume. Here are ten developments shaping that trend: ...

Scientists have created swallowable microsphere “pills” packed with engineered bacteria that can detect signs of gut disease, ...

UCLA research finds that fewer than one in four eligible younger adults completed colorectal cancer screenings after the ...

Chinese researchers have developed a new sensor made of tiny microspheres packed with blood-sensing bacteria that detect ...

Medical device maker Abbott Laboratories is nearing a potential takeover of cancer test maker Exact Sciences Corp, Bloomberg ...

Move over, colonoscopies—researchers report in ACS Sensors that they've developed a sensor made of tiny microspheres packed ...

Since 2021, over 41,000 Rhode Islanders have relied on enhanced Obamacare subsidies to afford health insurance. What happens ...

Abbott Laboratories is in talks to buy Exact Sciences, a company known for its Cologuard cancer test. Reports say the ...

UCLA research finds that fewer than 1 in 4 eligible younger adults completed colorectal cancer screenings after the United States Preventive Services Task Force (USPSTF) lowered the recommended ...

Bloomberg reports today that Abbott (NYSE: ABT) is close to a deal to acquire diagnostics developer Exact Sciences (Nasdaq:EXAS).

Move over, colonoscopies - researchers report in ACS Sensors that they've developed a sensor made of tiny microspheres packed with blood-sensing bacteria that detect markers of gastrointestinal ...